Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: Possible endogenous toxin to serotonin neurons

Journal of Neuroscience

Volumn 18, Issue 18, 1998, Pages 7111-7117

  Kuhn, Donald M ^a,b   Arthur Jr , Robert ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b School of Medicine ^*  (United States)

Author keywords

Dopamine; Neurotoxic amphetamines; Quinones; Quinoproteins; Serotonin; Tryptophan hydroxylase

Indexed keywords

DOPAMINE; QUINONE DERIVATIVE; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

ARTICLE; CATALYSIS; ENZYME INACTIVATION; NEUROTOXICITY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; SEROTONINERGIC NERVE CELL;

EID: 0032531095     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-18-07111.1998     Document Type: Article

References (17)

1. Anthony C (1996) Quinoprotein-catalyzed reactions. Biochem J 320:697-711.
2. Berman SB, Hastings TO (1997) Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species. J Neurochem 69:1185-1195.
3. Berman SB, Zigmond MJ, Hastings TG (1996) Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J Neurochem 67:593-600.
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Brunmark A, Cadenas E (1989) Redox and addition chemistry of quinoid compounds and its biological implications. Free Radic Biol Med 7:435-477.
6. Cohen G, Farooqui R, Kesler N (1997) Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. Proc Natl Acad Sci USA 94:4890-4894.
7. Darmon MC, Guibert B, Leviel V, Ehret M, Maitre M, Mallet J (1988) Sequence of two mRNAs encoding active rat tryptophan hydroxylase. J Neurochem 51:312-316.
8. Denu JM, Tanner KG (1998) Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry 37:5633-5642.
9. D'Sa C, Arthur Jr RE, States JC, Kuhn DM (1996a) Tryptophan hydroxylase: cloning and expression of the rat brain enzyme in mammalian cells. J Neurochem 67:900-906.
10. D'Sa C, Arthur Jr RE, Kuhn DM (1996b) Expression and deletion mutagenesis of tryptophan hydroxylase fusion proteins: delineation of the enzyme catalytic core. J Neurochem 67:917-926.
11. Filloux F, Townsend JT (1993) Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp Neurol 119:79-88.
12. Fleckenstein AE, Beyeler ML, Jackson JC, Wilkins DG, Gibb JW, Hanson GR (1997) Methamphetamine-induced decrease in tryptophan hydroxylase activity: role of 5-hydroxytryptaminergic transporters. Eur J Pharmacol 324:179-186.
13. Gibb JW, Johnson M, Elayan I, Lim HK, Matsuda L, Hanson GR (1997) Neurotoxicity of amphetamines and their metabolites. NIDA Res Monogr 173:128-145.
14. Gieseg SP, Simpson JA, Charlton TS, Duncan MW, Dean RT (1993) Protein-bound 3,4-dihydroxyphenylalanine is a major reductant formed during hydroxyl radical damage to proteins. Biochemistry 32:4780-4786.
15. Graham DG (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 14:633-643.
16. Graham DG, Tiffany SM, Bell Jr WR, Gutknecht WF (1978) Autooxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds toward C1300 neuroblastoma cells in vitro. Mol Pharmacol 14:644-653.
17. Green AR, Cross AJ, Goodwin GM (1995) Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy"). Psychopharmacology (Berl) 119:247-260.